A detailed history of Cornerstone Planning Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 115 shares of NVS stock, worth $11,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Previous 99 16.16%
Holding current value
$11,942
Previous $10.9 Million 16.87%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$106.13 - $120.89 $1,698 - $1,934
16 Added 16.16%
115 $12.7 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $4,998 - $5,797
54 Added 120.0%
99 $10.9 Million
Q1 2024

May 07, 2024

BUY
$95.27 - $108.47 $4,287 - $4,881
45 New
45 $4.38 Million
Q2 2023

Aug 15, 2023

SELL
$92.52 - $104.91 $15,173 - $17,205
-164 Reduced 91.62%
15 $1.51 Million
Q4 2022

Feb 14, 2023

BUY
$75.55 - $92.52 $13,523 - $16,561
179 New
179 $16.5 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.